Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Unknown 2Completed 2Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gynecologic 5Gastrointestinal 3

Conditions

Breast Neoplasms 15Prostatic Neoplasms 9Colorectal Neoplasms 7Ovarian Neoplasms 5Endometrial Neoplasms 5Colonic Neoplasms 5Rectal Neoplasms 4Colorectal Neoplasms, Hereditary Nonpolyposis 4Pancreatic Neoplasms 3Leukemia, Myeloid, Acute 3Brain Neoplasms 3Urogenital Neoplasms 2Neoplastic Syndromes, Hereditary 2Neoplasms, Unknown Primary 2Neoplasm Metastasis 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Leukemia 2Hereditary Breast and Ovarian Cancer Syndrome 2Hematologic Neoplasms 2Glioma 2Carcinoma, Intraductal, Noninfiltrating 2Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8 1Tuberous Sclerosis 1Thyroid Neoplasms 1Spinal Cord Neoplasms 1

Interventions

Paclitaxel 42Carboplatin 35pembrolizumab 25Surveys and Questionnaires 23Letrozole 15Radiotherapy 14Megestrol Acetate 14Blood Specimen Collection 14Bevacizumab 13olaparib 12Metformin 12dostarlimab 10Indocyanine Green 10durvalumab 9Observation 9Medroxyprogesterone Acetate 9Cisplatin 9lenvatinib 8atezolizumab 8Early Intervention, Educational 8Counseling 8niraparib 7Sentinel Lymph Node Biopsy 7Radiation 7Methods 7Magnetic Resonance Spectroscopy 7Lymph Node Excision 7Hysterectomy 7Everolimus 7abemaciclib 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Endometrial Neoplasms × Genetic Testing × Clear all
NCT03460483 2025-10-03

OPTEC

Ohio State University Comprehensive Cancer Center

Phase NA Completed
1,001 enrolled
GastrointestinalGynecologic

Colorectal Neoplasms, Hereditary Nonpolyposis, Endometrial Neoplasms

NCT05591131 2025-02-21

GTM-I

Augusta University

Phase NA Active not recruiting
21 enrolled
Gynecologic

Ovarian Neoplasms, Endometrial Neoplasms

NCT03322176 2019-01-23

Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing

Data Collection Analysis Business Management

Unknown
200 enrolled
GastrointestinalGynecologic

Colonic Neoplasms, Endometrial Neoplasms

NCT01850654 2018-06-28

OCCPI

Ohio State University Comprehensive Cancer Center

Phase NA Completed
3,470 enrolled
GastrointestinalGynecologic

Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Rectal Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT03338985 2018-01-05

Role of Senescence in the Development of Endometrial Cancer

CHU de Reims

Phase NA Unknown
140 enrolled
Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡